Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol

INTRODUCTION: The dramatic increase of the incidence of infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) has led to an increase of 50% of carbapenem consumption all around Europe in only 5 years. This favours the spread of carbapenem-resistant Gram-negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnier, Marc, Gallah, Salah, Vimont, Sophie, Benzerara, Yahia, Labbe, Vincent, Constant, Anne-Laure, Siami, Shidasp, Guerot, Emmanuel, Compain, Fabrice, Mainardi, Jean-Luc, Montil, Mélissa, Quesnel, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367973/
https://www.ncbi.nlm.nih.gov/pubmed/30782909
http://dx.doi.org/10.1136/bmjopen-2018-024561

Ejemplares similares

Ejemplares similares